We are live on
!
Find out more
WSA
Wall Street Associates Portfolio holdings
AUM
$151M
1-Year Est. Return
30.3%
This Fund
S&P 500
This Quarter
Est. Return
+11.79%
1 Year Est. Return
+30.3%
3 Year Est. Return
+94.41%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.06B
AUM Growth
+$16.2M
(+1.5%)
Cap. Flow
-$34.7M
Cap. Flow
% of AUM
-3.28%
Top 10 Holdings %
Top 10 Hldgs %
16.21%
Holding
377
New
60
Increased
44
Reduced
155
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
El Pollo Loco
LOCO
|
+$7.56M |
| 2 |
PGTI
PGT, Inc.
PGTI
|
+$7.35M |
| 3 |
Travere Therapeutics
TVTX
|
+$7.25M |
| 4 |
CCRN
Cross Country Healthcare
CCRN
|
+$6.91M |
| 5 |
TTSH
Tile Shop Holdings
TTSH
|
+$6.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SQBK
SQUARE 1 FINANCIAL INC COM
SQBK
|
+$11.1M |
| 2 |
Vanda Pharmaceuticals
VNDA
|
+$9.39M |
| 3 |
ZOES
Zoe's Kitchen, Inc.
ZOES
|
+$7.88M |
| 4 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
+$7.05M |
| 5 |
SPS Commerce
SPSC
|
+$7.02M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.06% |
| 2 | Technology | 22.46% |
| 3 | Consumer Discretionary | 14.63% |
| 4 | Industrials | 9.77% |
| 5 | Communication Services | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANAC
101
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $3.46M | 0.33% |
59,830
-11,012
| -16% | -$468K |
|
|
PES
102
DELISTED
Pioneer Energy Services Corp.
PES
| $3.42M | 0.32% |
630,200
-16,300
| -3% | -$81.2K |
|
|
NVDQ
103
DELISTED
Novadaq Technologies Inc.
NVDQ
| $3.29M | 0.31% |
202,507
-201,009
| -50% | -$2.99M |
|
|
MDSO
104
DELISTED
Medidata Solutions, Inc.
MDSO
| $3.1M | 0.29% |
63,180
-1,000
| -2% | -$46.3K |
|
|
GLUU
105
DELISTED
Glu Mobile Inc.
GLUU
| $3.05M | 0.29% |
608,100
-11,900
| -2% | -$53.2K |
|
106
Vince Holding Corp
VNCE
$86.8M
| $3.03M | 0.29% |
16,340
-4,053
| -20% | -$907K |
|
107
Orion Energy Systems
OESX
$80.6M
| $3.01M | 0.28% |
95,760
-1,390
| -1% | -$57K |
|
|
XLRN
108
DELISTED
Acceleron Pharma
XLRN
| $3.01M | 0.28% |
79,000
-3,700
| -4% | -$147K |
|
109
Neogen
NEOG
$2.5B
| $3M | 0.28% |
170,981
+16,554
| +11% | +$303K |
|
|
BAS
110
DELISTED
Basis Energy Services, Inc.
BAS
| $2.97M | 0.28% |
751
-16
| -2% | -$60K |
|
111
Standard BioTools
LAB
$314M
| $2.95M | 0.28% |
70,069
+14,089
| +25% | +$557K |
|
112
Belden
BDC
$5.19B
| $2.95M | 0.28% |
+31,496
| New | +$2.71M |
|
113
Nuwellis
NUWE
$543K
| – | – |
0
| – | – |
|
114
Verastem
VSTM
$610M
| $2.85M | 0.27% |
23,392
-1,116
| -5% | -$117K |
|
|
ULTI
115
DELISTED
Ultimate Software Group Inc
ULTI
| $2.83M | 0.27% |
16,680
+2,504
| +18% | +$397K |
|
|
TVRD
116
Tvardi Therapeutics
TVRD
$23.4M
| $2.78M | 0.26% |
7,675
-300
| -4% | -$114K |
|
|
AKRX
117
DELISTED
Akorn Inc
AKRX
| $2.66M | 0.25% |
56,025
-17,732
| -24% | -$805K |
|
|
MTLS
118
Materialise
MTLS
$396M
| $2.64M | 0.25% |
377,700
-2,450
| -0.6% | -$20.1K |
|
119
AtriCure
ATRC
$2.11B
| $2.64M | 0.25% |
128,647
-2,700
| -2% | -$52.3K |
|
120
Veracyte
VCYT
$3.8B
| $2.62M | 0.25% |
360,500
-6,200
| -2% | -$50.8K |
|
|
AXAS
121
DELISTED
Abraxas Petroleum Corp
AXAS
| $2.6M | 0.25% |
40,000
| – | – |
|
|
PRXL
122
DELISTED
Parexel International Corp
PRXL
| $2.6M | 0.25% |
37,619
+8,866
| +31% | +$565K |
|
|
EXAM
123
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
| $2.57M | 0.24% |
61,754
-1,100
| -2% | -$44.3K |
|
124
Comscore
SCOR
$109M
| $2.56M | 0.24% |
2,503
-45
| -2% | -$42.4K |
|
|
CY
125
DELISTED
Cypress Semiconductor
CY
| $2.56M | 0.24% |
+181,086
| New | +$2.68M |
|
Similar funds
CF
VWM
HH
NSCP
EEG
BC
WRHAM
SRP
Wall Street Associates's Q1 2015 Portfolio in Review
As of Q1 2015, Wall Street Associates held 377 positions worth $1.06B, up 1.5% from $1.04B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Wall Street Associates withdrew a net $34.7M in Q1 2015, closing 55 positions and reducing 155 holdings. Its most notable exit was SQUARE 1 FINANCIAL INC COM, an estimated $11.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Wall Street Associates opened a new position in El Pollo Loco worth $7.78M.
- Wall Street Associates's largest Q1 2015 buy was El Pollo Loco: 303,700 shares worth $7.78M.
- Wall Street Associates added most to Travere Therapeutics in Q1 2015, an estimated $7.25M increase.
- Wall Street Associates's biggest Q1 2015 reduction was AUSPEX PHARMACEUTICALS INC COM STK (DE), cutting an estimated $7.05M.
- Wall Street Associates fully exited SQUARE 1 FINANCIAL INC COM in Q1 2015, selling an estimated $11.1M.
- Wall Street Associates's ten largest holdings make up 16% of its $1.06B portfolio in Q1 2015.
- Wall Street Associates opened 60 new positions and closed 55 in Q1 2015.
- Wall Street Associates's portfolio value rose 1.5% quarter-over-quarter to $1.06B.
Based on Wall Street Associates's 13F filing for Q1 2015, filed 14 May 2015.